Skip to content

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

Suspected Sarcoidosis

This randomized pilot clinical trial aims to examine whether sample collection with Franseen-type needles are effective for the diagnosis of sarcoidosis, as defined by improved sample quality for pathological diagnosis compared to the conventional Menghini-type needle.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* -Any adult patient aged 18 years or older with enlarged mediastinal and/or hilar lymph nodes
* (≥10 mm short-axis diameter on a CT scan), suspected as having sarcoidosis based on clinical
* history, physical exam, and other investigations, and booked for EBUS-TBNA.

Exclusion Criteria:

* -Patients that are unable to provide informed consent

- Patients with lymphadenopathy strongly suspected to be secondary to other diseases based on
* clinical history, physical exam, and/or other investigations (e.g., lung cancer, lymphoma,
* infection).

Study Location

Toronto General Hospital
Toronto General Hospital
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Judy McConnell, BSc.Hon, CCRP

[email protected]
416-581-7486
Backup Contact

a

Study Sponsored By
University Health Network, Toronto
Participants Required
More Information
Study ID: NCT06220526